

How to Manage Tardive Dyskinesia with FDA-Approved Medications
Tardive dyskinesia (TD) emerges as a complex movement disorder often linked to prolonged neuroleptic or antipsychotic medication use. While newer antipsychotics like aripiprazole offer reduced risk, managing TD requires a careful review of treatments. The introduction of FDA-approved medications such as Ingrezza and Austedo has revolutionized TD management, offering symptom relief. Effective treatment strategies, including […]
3 min read